Eli Lilly and Company (LLY)

業務介紹

禮來公司在全球範圍內發現、開發和銷售人用藥品。它提供以下產品:

用於糖尿病的Basaglar、Humalog、Humalog Mix 75/25、Humalog U-100、Humalog U-200、Humalog Mix 50/50、insulin lispro、insulin lispro protamine、insulin lispro mix 75/25、Humulin、Humulin 70/30、Humulin N、Humulin R和Humulin U-500;用於2型糖尿病的Jardiance、Trajenta和Trulicity。

公司提供Alimta用於非小細胞肺癌和惡性胸膜間皮瘤;Cyramza用於轉移性胃癌、胃食管交界腺癌、轉移性非小細胞肺癌、轉移性結直腸癌和肝細胞癌;Erbitux用於結直腸癌和各種頭頸部癌症;Retevmo用於轉移性非小細胞肺癌、髓樣甲狀腺癌和甲狀腺癌;Tyvyt用於復發或難治性典型霍奇金淋巴瘤和非鱗狀非小細胞肺癌;Verzenio用於HR+、HER2-轉移性乳腺癌、淋巴結陽性和早期乳腺癌。

公司還提供Olumiant用於類風濕性關節炎;Taltz用於斑塊性牛皮癬、銀屑關節炎、強直性脊柱炎和非放射性軸性脊柱關節炎。

公司提供Cymbalta用於抑鬱性障礙、糖尿病周圍神經痛、廣泛性焦慮障礙、纖維肌痛和慢性肌肉骨骼疼痛;Emgality用於偏頭痛預防和發作性叢發性頭痛;Zyprexa用於精神分裂症、I型雙相情感障礙和雙相情感障礙維持治療。

公司的其他產品包括用於COVID-19的Bamlanivimab和etesevimab、Bebtelovimab,用於勃起功能障礙和良性前列腺增生的Cialis,以及用於骨質疏鬆症的Forteo。

禮來公司成立於1876年,總部位於印第安納州印第安納波利斯。



Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

公司網址

https://www.lilly.com